Form by GBY Review

What Form by GBY charges

• GHK-Cu: $199 — per unit — the page prints "$199 per unit" for the cream, not a monthly rate, though it also promises monthly delivery
• Glutathione: $199/mo — per month, on the standalone glutathione page
• NAD+: $199/mo — per month; one figure covers three routes, which the page names together

Form by GBY also sells 1 compound this site boards without publishing a price for it: Sermorelin.

A unit price that says it is a unit price

The copper-peptide page prints its figure as a charge per unit, not per month, while promising monthly delivery in the next sentence.

That distinction is unusual and worth crediting: a great many sellers on this roster print a bare figure and let a template supply the word "month".

The glutathione and NAD+ pages do print a monthly figure, and each is filed as one. The NAD+ figure covers an injectable, a topical and a sublingual route together, which the page names in one line.

The weight-loss price buys three things

This seller's flagship is described on its own homepage as a metabolic drug, vitamin B12 and glycine together in one compounded prescription.

All three of its weight-loss options are that formula, so no figure it publishes is scoped to semaglutide or to tirzepatide on their own.

A second bundle is described as three vials — a weight-loss drug, an advanced NAD+ preparation and glutathione — at a single monthly figure. That is a bundle price, and it is not filed against any of its parts.

Two figures for glutathione, and which one is recorded

The bundle block prints one monthly figure beside a glutathione description. The standalone glutathione page prints a much lower monthly figure.

Both were read on the same day. They are not reconciled anywhere on the site.

The standalone page is the one scoped to glutathione alone, so that is the figure on this record, and the conflict is noted rather than averaged away.

What it does and does not disclose

Each product page carries an FAQ that asks whether the compounded medicine is FDA-approved and answers no, adding that the FDA does not review compounded products for safety, effectiveness or quality.

It says medication comes from a licensed pharmacy and is delivered monthly, without naming the pharmacy.

No state list is published and no certificate of analysis is reachable. A meaningless address on this host returns a not-found response, so both are absences rather than an artefact of the host.

How we verified this

• Read each single-compound page and recorded the figure with the unit the page itself prints, unit or month.
• Read the homepage description of the flagship formula and confirmed it names three components, then declined to file its figures under either weight-loss drug.
• Read the second bundle's own description, confirmed it is three vials, and declined to file its figure against any part.
• Recorded both glutathione figures as read and did not average them, noting which one is scoped to the compound alone.
• Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
• Screened the brand and the operating name against the live federal warning-letter table, filtering locally because the table's own search parameter returns every record whatever is typed into it, with a positive and a nonsense control in the same run.